Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology reported impressive Q3 2020 results with total revenues at $734.1 million, marking a 20.9% increase year-over-year. The GAAP diluted net income per share was $1.76, while non-GAAP amounted to $2.25. Clear Aligner volume soared by 28.7% to 496.1 thousand cases. The operating margin improved to 24.1%, a significant 44.8 points increase sequentially. Align also celebrated 9 million Invisalign patients and launched innovative products enhancing treatment options.
Align Technology has announced the launch of Invisalign G8 with SmartForce Aligner Activation, enhancing treatment predictability for crowding, crossbite, and deep bite cases. Leveraging data from over 9 million Invisalign patients, this innovation optimizes tooth movements. Key features include automatic force application and precision bite ramps to improve treatment outcomes, with a reported 2x improvement in incisor intrusion predictability. Invisalign G8 will be available globally in Q1 2021.
Align Technology has filed a lawsuit against 3Shape for infringing seven additional patents in the U.S. District Court for the Western District of Texas. This lawsuit asserts over 30 patents against 3Shape, following a previous determination by the ITC that 3Shape’s scanners violated Align's patents. Align aims to protect its intellectual property and intends to assess further patent assertions against 3Shape if necessary.
Align Technology, Inc. (Nasdaq: ALGN) will announce its third quarter 2020 financial results on October 21, 2020, after market close at 4:00 p.m. ET. The results will be accessible on the Investor Relations section of their website. A conference call is scheduled for 4:30 p.m. ET to discuss these results, available via audio webcast. An archived replay will be accessible within an hour post-call and will be available for one month. Align Technology specializes in clear aligners, intraoral scanners, and CAD/CAM software, improving patient outcomes through advanced digital dentistry.
Align Technology has reached a significant milestone by treating its 1 millionth patient in the Asia Pacific with the Invisalign system, the leading clear aligner technology. This announcement emphasizes the growing adoption of Invisalign, with over 8 million patients worldwide. The milestone was celebrated by highlighting Ayumu Saito, a 23-year-old Olympic hopeful, as the 1 millionth patient. Align Tech is committed to enhancing patient outcomes through digital orthodontics and has contributed over $1 million to Operation Smile, supporting children and adults born with cleft conditions.
Align Technology announced a multi-year partnership with the New Orleans Saints, designating Invisalign as the 'Official Smile' partner. This collaboration aims to boost awareness and demand for Invisalign treatments through social and digital platforms. The partnership includes promoting defensive end Cam Jordan's Invisalign experience, benefiting the Youth Empowerment Project (YEP) in providing makeover treatments to underserved youth. Align has treated over 8 million patients with Invisalign, focusing on transforming smiles and enhancing community engagement.
Align Technology launched the Align Digital and Practice Transformation (ADAPT) service to aid orthodontic practices in transitioning to digital workflows. This fee-based consulting service aims to optimize operational processes, enhancing patient experiences and overall practice efficiency.
Practices involved in the pilot saw an average revenue increase of 20% and a 15% profit rise within six months of ADAPT implementation. The service will be globally available across the EMEA, APAC regions, and the US in late 2020.
Align Technology reported Q2 2020 total revenues of $352.3 million, down 41.3% year-over-year. The GAAP net loss per diluted share was $(0.52), and non-GAAP net loss was $(0.35). Invisalign volume fell to 221.9 thousand cases, a 41.2% decrease. The company acquired exocad for $430 million, aiming to enhance its digital platform. Although practices are reopening, uncertainty around the pandemic's impact persists, leading to no guidance for Q3 2020.
Align Technology (Nasdaq: ALGN) announced the awarding of nine research grants as part of its Annual Research Award Program, reflecting growing global interest in dental and orthodontic treatments. The grants support various orthodontic research projects, validating the efficacy of the Invisalign system in clinical applications. Award recipients include institutions from North America, Europe, and Asia Pacific, addressing topics such as the effects of orthodontic appliances and treatment methodologies.
Align Technology will announce its second quarter 2020 financial results on July 22, 2020, after market close. The results will be available at 4:00 p.m. ET on their Investor Relations website. A conference call will follow at 4:30 p.m. ET to discuss the results. Investors can listen to the call live online and participate via phone. An archived audio webcast and telephonic replay will be available after the call. Align Technology is known for its Invisalign system and digital dental solutions, having treated over 8 million patients.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
